Skip to main content
IMRX logo
IMRX
(NASDAQ)
Immuneering Corporation
$4.27-- (--)
Loading... - Market loading

Immuneering (IMRX) Stock Price & Financial Analysis

Immuneering Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.47 - $4.67
52-Week High$10.08
52-Week Low$1.66
Open$4.49
Volume1.06M
Average Volume (3M)1.67M
Market Cap197.17M
Shares Outstanding44.01M
Price to Book (P/B)0.90
EV/EBITDA-1.22
50-Day MA$5.27
200-Day MA$5.84
52-Week Change108.29%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immuneering

What is the current stock price for IMRX?

As of the latest trading session, IMRX stock trades at $4.48. The 52-week range is $1.66–$10.08, with a day range of $4.47–$4.67.

What is the P/E ratio for IMRX?

The P/E ratio (Price-to-Earnings) for IMRX is shown in the Key Statistics section. This valuation metric helps compare Immuneering Corporation to industry peers.

Does IMRX pay dividends?

Immuneering does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMRX?

Based on 1 analyst, the consensus for IMRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMRX?

Immuneering's market capitalization is $197.2M, classifying it as a micro-cap company. Immuneering operates in the Healthcare sector within the Biotechnology industry.